Opens in a new tab

Dr. Yu Minbin

Chinese name: 余敏斌
Professor, Chief Physician, Doctoral Supervisor . Glaucoma
Dr. Yu Minbin is academic leader of glaucoma and professor at Zhongshan Ophthalmic Center, Sun Yat-sen University. A recipient of the State Council Special Allowance, he specialises in the early diagnosis and long-term management of glaucoma and leads clinical trials on laser and surgical treatments to preserve vision.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

30+ years
Ophthalmic practice
nearly 10,000
Glaucoma surgeries
90+
First/corresponding-author SCI papers

  • The Physician

About Dr. Yu Minbin

Dr. Yu Minbin is academic leader of glaucoma and professor at the Zhongshan Ophthalmic Center, Sun Yat-sen University. He has devoted his career to the clinical management and pathophysiology of glaucoma, with a focus on early diagnosis, intraocular pressure control and the preservation of visual function. He served as vice director of the centre and is a recipient of the State Council Special Allowance and recognition as a national outstanding young expert. His research includes clinical trials of selective laser trabeculoplasty and studies of corneal biomechanics in normal-tension glaucoma, and he has published extensively on glaucoma diagnosis and treatment.
1、Academic leader of glaucoma at the Zhongshan Ophthalmic Center
2、Former Vice Director of the Zhongshan Ophthalmic Center
3、Recipient of the State Council Special Allowance and national outstanding young expert recognition
4、Deputy head of the Glaucoma Group of the Chinese Medical Association Ophthalmology Branch
5、Leader of clinical trials on selective laser trabeculoplasty in open-angle glaucoma
6、Author of more than 90 papers as first or corresponding author

Dr. Yu Minbin ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Glaucoma diagnosis and management

He diagnoses and treats open-angle, angle-closure and normal-tension glaucoma, using perimetry, imaging and intraocular pressure monitoring to detect disease early and carefully tailor medical, laser and surgical treatment to each patient to preserve vision and quality of life over the long term.

Laser treatment for glaucoma

He performs selective laser trabeculoplasty and other laser procedures to effectively lower intraocular pressure, and led clinical research demonstrating the responsiveness of open-angle glaucoma and ocular hypertension to laser treatment, helping patients avoid or delay surgery and preserve visual function.

Surgical glaucoma treatment

He performs trabeculectomy and other filtering surgery for patients whose pressure is not controlled by medication or laser, using careful, individualised postoperative management to maintain drainage and protect the optic nerve over time and preserve long-term vision and functional independence.

More: ocular hypertension——monitoring; angle-closure glaucoma——laser iridotomy; normal-tension glaucoma——management; visual field testing——follow-up; optic nerve imaging——assessment

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Laser in Glaucoma and Ocular Hypertension (LiGHT) China Trial: Baseline Characteristics of High-Tension versus Normal-Tension Glaucoma
This Zhongshan Ophthalmic Center study analysed 1,105 open-angle glaucoma eyes from 622 LiGHT China participants, comparing normal-tension and high-tension glaucoma. It assessed daytime intraocular pressure phasing and visual field defects, showing that short-term intraocular pressure fluctuation worsens hemifield asymmetry in normal-tension glaucoma, informing personalised glaucoma monitoring and treatment targets.
2. Pirfenidone as a Postoperative Antiscarring Agent in Experimental Glaucoma Filtration Surgery
A randomized controlled study at Zhongshan Ophthalmic Center evaluated pirfenidone eye drops after trabeculectomy in a rabbit glaucoma filtration model. Topical 0.5% pirfenidone significantly prolonged filtering bleb survival and reduced conjunctival scarring without ocular toxicity, suggesting a novel antiscarring strategy to improve glaucoma surgery outcomes and long-term intraocular pressure control.
3. A Novel Contact Lens Sensor System for Continuous Intraocular Pressure Monitoring in Human Eyes
Investigators at Zhongshan Ophthalmic Center evaluated a novel contact lens sensor system that continuously records intraocular pressure fluctuations in human eyes. The device showed acceptable accuracy, offering comfortable, wireless 24-hour intraocular pressure monitoring that may help clinicians detect nocturnal pressure spikes and better individualise glaucoma treatment and follow-up.
4. Dose-Effectiveness Optimization of Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma
This Zhongshan Ophthalmic Center cohort study characterised 229 refractory glaucoma eyes treated with micropulse transscleral cyclophotocoagulation using augmented dose protocols. A longer 240-second treatment achieved a 38.7% intraocular pressure reduction at 12 months, establishing a clear laser dose-response relationship that helps clinicians optimise this minimally invasive procedure.
5. Chronic Intraocular Pressure Elevation Eliminates Synapses and Dendritic Spines in the Primary Visual Cortex
Using a mouse model of chronic intraocular pressure elevation, Zhongshan Ophthalmic Center researchers found that synapses and dendritic spines are progressively eliminated in the primary visual cortex, revealing that glaucoma damages the optic nerve beyond the eye. These findings support neuroprotective strategies aimed at preserving central visual pathways alongside intraocular pressure lowering.
6. Endogenous Corticosteroid-Induced Open-Angle Glaucoma Secondary to an Adrenal Adenoma: A Case Report
Zhongshan Ophthalmic Center clinicians reported a 30-year-old woman who developed bilateral endogenous corticosteroid-induced open-angle glaucoma from a cortisol-secreting adrenal adenoma. Despite maximal medical therapy, intraocular pressure remained uncontrolled until trabeculectomy stabilised it near 10 mmHg, underscoring the need for systemic evaluation in atypical glaucoma and timely treatment to prevent optic nerve damage.
  • Affiliated Hospital

Where Dr. Yu Minbin practices

Guangzhou

Zhongshan Ophthalmic Center, Sun Yat-sen University

Chinese name: 中山大学中山眼科中心
Zhongshan Ophthalmic Center, China's largest public eye hospital and the country's only WHO Collaborating Centre for Eye Health and Vision, performs 100,000+ surgeries a year with a 93.83% day-surgery rate and serves 1.4 million annual outpatient visits.
Since 1835
191 years of eye care
100,000+
Annual eye surgeries
1.4 million
Annual outpatient visits
93.83%
Annual eye surgeries
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Yu Minbin?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Yu Minbin.